Mueller E E - OmicsDI

Show results for

Unknown (1843)
Transcriptomics (136)
Proteomics (87)
Genomics (17)
Metabolomics (9)
Models (1)

Organisms

Homo sapiens (72)
Mus musculus (41)
Arabidopsis thaliana (17)
Escherichia coli (16)
Campylobacter jejuni (13)
Campylobacter jejuni subsp. jejuni NCTC 11168 = ATCC 700819 (10)
Staphylococcus aureus (7)
Zea mays (5)
Rattus norvegicus (4)
Caenorhabditis elegans (3)
Drosophila melanogaster (3)
Citrus hybrid cultivar (3)
Legionella pneumophila subsp. pneumophila str. Philadelphia 1 (2)
Chlamydomonas reinhardtii (2)
Francisella tularensis (2)
Pseudomonas aeruginosa PAO1 (2)
Enterococcus faecalis (2)
Campylobacter jejuni subsp. jejuni 81-176 (1)
Oncorhynchus nerka (1)
marine metagenome (1)
Myxococcus xanthus (1)
Helicobacter cinaedi CCUG 18818 = ATCC BAA-847 (1)
Xenopus laevis (1)
Neisseria meningitidis (1)
Listeria monocytogenes (1)
Oryza sativa (1)
Nicotiana tabacum (1)
Acinetobacter baumannii (1)
Canis lupus familiaris (1)
Halobacterium salinarum NRC-1 (1)

Organisms

Enterococcus faecalis (2)

Repository

biostudies-arrayexpress (138)
pride (81)
EGA (9)
MetaboLights (8)
MassIVE (5)
ENA (5)
geo (2)
BioModels (1)
GNPS (1)
PeptideAtlas (1)

Tissue

Permanent cell line cell (8)
Brain (6)
Leaf (6)
Early embryonic cell (5)
Cell culture (4)
Microglial cell (4)
Astrocyte (3)
Blood (3)
Blood plasma (3)
Cerebral cortex neuron (2)
Embryonic stem cell (2)
Epithelial cell (2)
Mast cell (2)
Microvessel (2)
Plant cell (2)
T cell (2)
Amniotic fluid (1)
B cell (1)
Basal cell (1)
Blood cell (1)
Blood vessel (1)
Cerebellum (1)
Cerebrospinal fluid (1)
Embryo (1)
Fibroblast (1)
Gametophore (1)
Gastric cancer cell line (1)
Glial cell (1)
Gut (1)
Purkinje cell (1)

Disease

Alzheimer's disease (3)
Breast cancer (2)
Wounded; tumour (1)
Uterine Fibroid (1)
Chronic myelogenous leukemia (1)
Glioblastoma (1)
Breast carcinoma (1)
Normal (1)
Neuroblastoma (1)
CADASIL (1)
CAKUT (1)
Cardiovascular system disease (1)
Diffuse midline glioma (1)
Immune system (1)
Lymphoma (1)
Pancreatic cancer (1)

Technology Type

Mass Spectrometry (81)
Shotgun proteomics (46)
Data-independent acquisition (22)
Bottom-up proteomics (21)
Mass spectrometry (7)
Data-dependent acquisition (7)
Affinity purification coupled with mass spectrometry proteomics (5)
Gel-based experiment (3)
SRM/MRM (2)
Illumina HiSeq 2000 (1)
Mass spectrometry assay (1)
All-ion fragmentation (1)
Chemical cross-linking coupled with mass spectrometry proteomics (1)
SWATH MS (1)
Top-down proteomics (1)

Instrument Platform

Illumina HiSeq 1500 (6)
Illumina HiSeq 2500 (3)
Q Exactive HF (3)
Liquid Chromatography MS - negative - hilic (3)
Orbitrap Exploris 480 (2)
Liquid Chromatography MS - positive - reverse phase (2)
Ultrospec 3000 (1)
BD GasPak 150 Jar (1)
Illumina Genome Analyzer IIx (1)
Bioanalyser (1)
Variable Atmosphere Incubator (1)
Illumina Genome Analyzer II (1)
RNeasy Plus Kit (Qiagen) (1)
NovaSeq PE150 (1)
Illumina MiSeq (1)
NextSeq 550 (1)
Illumina NovaSeq 6000 (1)
Illumina HiSeq 2000 (1)
Agilent 7890A GC with 5975C inert XL MSD (1)
Bruker Daltonics instrument model (1)
Varian NMR (1)
Orbitrap Fusion (1)
Q Exactive HF-X (1)
Exactive (Thermo Scientific) (1)
Gas Chromatography MS - Positive (GC-MS (Positive)) (1)
Liquid Chromatography MS - negative - reverse-phase (1)
Liquid Chromatography MS - positive - hilic (1)
Liquid Chromatography MS - positive - reverse-phase (1)
Liquid chromatography MS/MS - Negative (1)
Liquid chromatography MS/MS -Positive (1)

Publication Date

2026 (21)
2023 (18)
2014 (17)
2009 (17)
2013 (16)
2010 (16)
2022 (15)
2015 (15)
2024 (14)
2012 (13)
2011 (13)
2021 (12)
2016 (9)
2020 (8)
2017 (8)
2007 (6)
2008 (5)
2018 (5)
2019 (4)
2025 (3)
2006 (2)

CHEBI ID

CHEBI:15422 (2)
CHEBI:15741 (2)
CHEBI:15781 (2)
CHEBI:15846 (2)
CHEBI:16027 (2)
CHEBI:16761 (2)
CHEBI:17138 (2)
CHEBI:17858 (2)
CHEBI:18009 (2)
CHEBI:27732 (2)
CHEBI:30769 (2)
CHEBI:30915 (2)
CHEBI:4828 (2)
CHEBI:48928 (2)
CHEBI:1148 (1)
CHEBI:133246 (1)
CHEBI:143859 (1)
CHEBI:15354 (1)
CHEBI:15414 (1)
CHEBI:15584 (1)
CHEBI:15688 (1)
CHEBI:15713 (1)
CHEBI:15721 (1)
CHEBI:15728 (1)
CHEBI:15891 (1)
CHEBI:15978 (1)
CHEBI:15996 (1)
CHEBI:16020 (1)
CHEBI:16070 (1)
CHEBI:16077 (1)

Metabolite Name

1-Nonanol (2)
2-Nonanol (2)
6-Hydroxyluteolin 7-glucoside (2)
Arachidic acid (2)
Avocadene (2)
Citrate (2)
Dodecanedioic acid (2)
Fructose-6-phosphate (2)
NADH (2)
Phosphoglycerate (2)
Pseudouridine (2)
Ricinoleic acid (2)
Sebacic acid (2)
Tauroursodeoxycholic acid (2)
Tetradecanedioic acid (2)
Traumatic acid (2)
Undecanedioic acid (2)
Uridine (2)
(+)-12-Neophoen-3beta-ol (1)
(+)-12-hydroxy-9Z-hexadecenoic acid (1)
(+)-12a-Hydroxyerythynone (1)
(+)-14,15-Epoxy-thapsan-14-ol (1)
(+)-15S-hydroxy-hexadecanoic acid (1)
(+)-16-Gammaceren-3beta-ol (1)
(+)-2-Himachalen-7-ol (1)
(+)-2-Sterpurene-6,12,15-triol (1)
(+)-2-Sterpurene-6-ol (1)
(+)-20-Taraxasten-3beta-ol (1)
(+)-22(29)-Hopen-6alpha-21beta-diol (1)
(+)-24-Dammarene-3alpha,12beta,20S-triol (1)

IsPrivate

False (1)

First Public Date

2025 (1)
2024 (1)
2022 (1)
2021 (1)
2018 (1)

Classification

bacteria (2)

Modelling Approach

Ordinary differential equation model (1)

Modification

15.99491 (1)
57.02146 (1)

Study type

Transcription profiling by array (105)
RNA-seq of coding RNA (13)
Unknown experiment type (3)
Comparative genomic hybridization by array (3)
ChIP-seq (3)
Methylation profiling by array (2)
RNA-seq of total RNA (2)
Plant - High-throughput sequencing (1)
Cell line - One-color microarray (1)
Animal - High-throughput sequencing (1)
ChIP-chip by array (1)
Transcription profiling by RT-PCR (1)
Other (1)

Release Date

2022 (238)
2021 (198)
2023 (190)
2024 (190)
2025 (164)
2020 (137)
2017 (97)
2018 (93)
2019 (92)
2015 (91)
2016 (84)
2014 (69)
2011 (55)
2012 (52)
2013 (50)
2009 (46)
2010 (44)
2026 (31)
2008 (20)
2007 (8)
2006 (7)
2002 (7)
2005 (5)
2001 (5)
2004 (3)
2000 (2)
1998 (2)
2003 (1)

Lab affiliation

Administrerende Direktør • Novo Nordisk Foundation Center for Protein Research (6)
DZNE Munich, Neuroproteomics, Feodor-Lynen-Str. 17, 81377 München, Germany (5)
DZNE Munich, Neuroproteomics, Feodor-Lynen Str. 17, 81377 Munich, Germany (3)
Microbial Natural Products, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS). Helmholtz Centre for Infection Research (HZI). Department of Pharmacy at Saarland University, Campus Building E8.1, 66123 Saarbrücken, Germany. (3)
USDA ARS; Boyce Thompson Institute; Cornell University (3)
Executive Director, Professor Novo Nordisk Foundation Center for Protein Research Proteomics Program (2)
Forschungszentrum Juelich ZEA-3 Analytics Wilhelm-Johnen-Str D-52425 Juelich Germany (2)
Institute for Stroke and Dementia Research (ISD) Klinikum der Universität München Feodor-Lynen-Str. 17 81377 Munich Germany (2)
1. Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, AUSTRALIA 2. Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, NSW, AUSTRALIA 3. Paediatric Program, Mark Hughes Foundation Centre for Brain Cancer Research, College of Health, Medicine, and Wellbeing, Callaghan, NSW, AUSTRALIA (1)
1. Istitituto Sperimentale Italiano L. Spallanzani,Milano, Italy; 2. Dipartimento di Scienze Veterinarie e Sanità Pubblica, Università degli Studi di Milano, Milano, Italy. (1)
Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, Australia (1)
CECAD Institut - University of Cologne Joseph-Stelzmann-Strasse 26 50931 Cologne Germany (1)
CNIO (1)
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences Lazarettgasse 14, AKH BT 25.3 1090 Vienna, Austria (1)
Centre for Advanced Imaging, The University of Queensland, St Lucia, QLD 4072, Australia. Centre for Biodiversity Dynamics, Department of Biology, NTNU, N-7491 Trondheim, Norway Centre for Ecological and Evolutionary Synthesis, Department of Biosciences, University of Oslo, 0316 Oslo, Norway (1)
Centre for Genomic Regulation (CRG), the Barcelona Institute of Science and Technology, Carrer Dr. Aiguader 88, Barcelona 08003, Spain. (1)
Core facility for Mass Spectrometry, ZMBH, University of Heidelberg, Im Neuenheimer Feld 282, 69120 Heidelberg, Germany (1)
Core facility for mass spectrometry and proteomics, ZMBH, University Heidelberg, Im Neuenheimer Feld 282, 69120 Heidelberg, Germany (1)
DZNE - German Center for Neurodegenerative Diseases Munich Neuroproteomics Feodor-Lynen Str. 17 D-81377 Munich Germany (1)
DZNE Munich Neuroproteomics Feodor-Lynen Str. 17 81377 Munich Germany (1)
Department of Clinical Microbiology, Sahlgrenska University Hospital, Gothenburg, Sweden (1)
Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway (1)
Department of Dermatology and Venereology, University of Cologne, Faculty of Medicine, and University Hospital of Cologne, Cologne, Germany (1)
Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany (1)
Dept. Proteomics and Signal Transduction Max Planck Institute of Biochemistry (1)
Dept. of Medicine 1, Laboratory of Infection Biology, Medical University of Vienna (1)
Dept. of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, 94305-5176, USA (1)
Developmental Genetics Unit, Institute of Biology, University of Kassel, Germany (1)
Division head of Proteomics of Stem Cells and Cancer Deutsches Krebsforschungszentrum (1)
Erasmus MC Neurology Lab. Neuro-Oncology and Clinical and Cancer Proteomics (1)

Tags

pathogen (2)
pathogen:bacterium (2)
xref:PubMed:38512984 (1)
xref:EuropePMC:PMC5933015 (1)
xref:PubMed:35913163 (1)

Previous page
1 / 210
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 210
Next page

Sort by:

Relevance

Page size

Transcription profiling of brain, liver and spleen from rats infected with Escherichia coli K1 and treated with capsule-selective endosialidase E

Transcription profiling of infected and treated (Capsule-Selective Endosialidase E Minimizes) of RNA isolated from brain/spleen/liver of rats with E.coli K1

ORGANISM(S): Rattus norvegicus

2010-01-10 | E-MEXP-2406 | biostudies-arrayexpress

1% 2% 5% 25% 50% 100% 13C-labeled E. coli protein

See metadata.xlsx for detailPan_062822_X1iso5.raw1%_13C_unlabeled_EcoliPan_062822_X2iso5.raw1%_13C_unlabeled_EcoliPan_062822_X3iso5.raw1%_13C_unlabeledEcoliPan_062822_X5.raw2%_13C_labeled_EcoliPan_062822_X6.raw2%_13C_labeled_EcoliPan_062822_X7.raw2%_13C_labeled_EcoliPan_062822_X19.raw5%_13C_labeled_...

ORGANISM(S): Escherichia coli

2024-06-14 | PXD041414 | Pride

Point mutations in the ygiV promoter region lead to cystobactamid resistance and reduced virulence in E. coli

ORGANISM(S): Escherichia coli

2024-10-11 | PXD047566 | Pride

Escherichia coli Fima Virulence Resistance Qseb Ygiv Cystobactamid Gyrase

Listeria monocytogenes EGD and EGD-e

Transcriptional profile after growth in MM (minimal medium (Premaratne et al. 2001) supplemented with 50 mM Glucose. Note: strain "EGD" has not been deposited at ATCC/NCTC. It is a derivative of the original Murray strain (Murray et al. 1926), obtained from S.H.E. Kaufmann. Strain "E...

ORGANISM(S): Listeria monocytogenes

2008-11-30 | E-GEOD-12146 | biostudies-arrayexpress

Cystobactamid resistant clinical isolates

Generated cystobactamid resistant clinical isolates of E. coli compared to WT show YgiV upregulation and fimbrial downregulation

ORGANISM(S): Escherichia coli

2024-10-11 | PXD051732 | Pride

Cystobactamids Amr Clinical isolates E. coli

Stereoscopic spatial graphical method of Mueller matrix: Global-Polarization Stokes Ellipsoid.

Not available

S-EPMC11329479 | biostudies-literature

Quantitative Brightness Analysis of Fluorescence Intensity Fluctuations in E. Coli.

Not available